会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明公开
    • 통증의 치료 또는 예방용 약학 조성물
    • 用于预防和治疗疼痛的药物组合物
    • KR1020100053027A
    • 2010-05-20
    • KR1020080111976
    • 2008-11-12
    • 주식회사 지엔티파마
    • 김기원권영배정낙신곽병주이영애
    • A61K31/075A61P23/00
    • PURPOSE: A composition containing an effective compound for pain for preventing neuropathic and inflammatory pain based on sigma 1 receptor suppression is provided. CONSTITUTION: A pharmaceutical composition contains a compound of chemical formula 1 or pharmaceutically acceptable salt thereof. In chemical formula 1, R1 is hydrogen or straight chain or side chain alkyl of C1-C6, and side chain alkyl, or cycloalkyl; R2 and R3 is straight chain or side chain alkyl of C1-C3; and R4 is straight chain or side chain linker containing C1-C4 alkyl or OH. The treatment or prevention for neuropathic or inflammatory pain is performed by administering a compound of chemical formula 1 or 2 or pharmaceutically acceptable salt.
    • 目的:提供一种含有基于西格玛1受体抑制的用于预防神经性和炎性疼痛的疼痛的有效化合物的组合物。 构成:药物组合物含有化学式1的化合物或其药学上可接受的盐。 在化学式1中,R 1是氢或C1-C6的直链或侧链烷基,和侧链烷基或环烷基; R2和R3是C1-C3的直链或侧链烷基; 并且R 4是含有C 1 -C 4烷基或OH的直链或侧链接头。 神经性或炎性疼痛的治疗或预防是通过施用化学式1或化合物2或其药学上可接受的盐来进行的。
    • 2. 发明公开
    • 신경세포사멸 또는 신경기능장애를 치료하기 위한 약학제제 및 병용용법
    • 治疗神经性死亡或神经性功能障碍的药物制备和组合治疗
    • KR1020070082440A
    • 2007-08-21
    • KR1020060015301
    • 2006-02-16
    • 주식회사 지엔티파마주식회사 아라온테크
    • 곽병주이영애신진희조성익노재성조제영김기원임향란이재근변한열
    • A61K33/14A61K31/60A61P25/28
    • A61K31/606A61K31/192A61K33/00A61K2300/00
    • A pharmaceutical preparation and combination therapy for treating neuronal cell death or neurological dysfunction is provided to inhibit both apoptosis and necrosis of neuronal cells by using synergism of an apoptosis inhibitor and lithium. The pharmaceutical preparation and combination therapy for treating neuronal cell death or neurological dysfunction comprises: an apoptosis inhibitor selected from benzylaminosalicylic acid derivatives represented by the formula(1), wherein X is CO, SO2 or (CH2)n in which n is an integer from 1 to 5, R1 is hydrogen, alkyl or alkanoyl, R2 is hydrogen or alkyl, R3 is hydrogen or acetyl, and R4 is phenyl optionally substituted by nitro, halogen, haloalkyl and C1-C5 alkoxy; and tetrafluorobenzyl derivatives represented by the formula(2), wherein R1, R2 and R3 are each independently hydrogen or halogen, R4 is hydroxy, alkyl, alkoxy, halogen, halogen-substituted alkoxy, alkanoyloxy or nitro, and R5 is carboxylic acid, ester having C1-C4 alkyl group, carboxyamide, sulfonic acid, halogen or nitro, and lithium or its pharmaceutically acceptable salts.
    • 提供用于治疗神经元细胞死亡或神经功能障碍的药物制剂和组合疗法,以通过使用凋亡抑制剂和锂的协同作用来抑制神经元细胞的凋亡和坏死。 用于治疗神经元细胞死亡或神经功能障碍的药物制剂和组合疗法包括:选自由式(1)表示的苄基氨基水杨酸衍生物的凋亡抑制剂,其中X为CO,SO 2或(CH 2)n,其中n为 1至5,R 1为氢,烷基或烷酰基,R 2为氢或烷基,R 3为氢或乙酰基,R 4为任选被硝基,卤素,卤代烷基和C 1 -C 5烷氧基取代的苯基; 和式(2)表示的四氟苄基衍生物,其中R 1,R 2和R 3各自独立地为氢或卤素,R 4为羟基,烷基,烷氧基,卤素,卤素取代的烷氧基,烷酰氧基或硝基,R 5为羧酸酯 具有C 1 -C 4烷基,羧酰胺,磺酸,卤素或硝基,以及锂或其药学上可接受的盐。